Eliminate
Cancer
from the world

We are developing drugs for pancreatic cancer and small cell lung cancer.

News

2025.12.09

We would like to thank everyone who attended the pitch by our CSO, Dr.Nakayama, at ILS 2025, and all who visited our booth.We are delighted that so many of you showed interest in our work.
We will continue to drive forward our research and development with the aim of bringing innovative technologies into practical use. Please stay tuned for our future developments.

2025.11.12

Keiichi Nakayama, our CSO, will be speaking at the ILS2025 Startup Pitch.
Please click here for more details about the presentation.

2025.10.31

Our research project, "Preclinical Study of innovative Metabolic Inhibitors Targeting Refractory Cancers," has been selected for the Japan Agency for Medical Research and Development (AMED)'s "Program for an Innovative Cancer Therapy Development."AMED Official Release

See More

Research Content

We are working on developing innovative treatments for highly malignant cancers (pancreatic cancer, small cell lung cancer, etc.)

Small Cell Lung Cancer Icon

Small Cell Lung Cancer

Developing small molecule compounds that inhibit metabolic enzymes highly expressed in small cell lung cancer, promoting new treatment realization.

Learn More
Pancreatic Cancer Icon

Pancreatic Cancer

Developing antibody therapy targeting signal paths specific to pancreatic cancer stem cells, aiming for clinical application.

Learn More
All Cancers Icon

All Cancers

Developing therapeutic agents targeting all solid tumors by inhibiting cancer stem cell-specific ubiquitin ligase E3.

Learn More